Redmile Group, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,551,000
+4.7%
694,9180.0%0.06%
+24.0%
Q2 2021$3,391,000
-4.3%
694,9180.0%0.05%0.0%
Q1 2021$3,544,000
-43.2%
694,918
-45.2%
0.05%
-34.2%
Q4 2020$6,242,000
-88.6%
1,268,718
-44.1%
0.08%
-92.4%
Q3 2020$54,585,000
-38.0%
2,268,7180.0%1.00%
-38.3%
Q2 2020$87,981,000
+11.6%
2,268,7180.0%1.62%
-26.5%
Q1 2020$78,861,000
-24.3%
2,268,7180.0%2.21%
-11.2%
Q4 2019$104,111,0002,268,7182.49%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 2,212,654$85,807,00018.79%
Versant Venture Management, LLC 1,854,229$71,907,001,00010.33%
SECTORAL ASSET MANAGEMENT INC 915,681$35,510,0003.26%
Consonance Capital Management LP 1,252,185$48,560,0002.91%
Redmile Group, LLC 2,268,718$87,981,0001.62%
SPHERA FUNDS MANAGEMENT LTD. 158,289$6,138,0000.58%
Rock Springs Capital Management LP 518,290$20,099,0000.55%
Parkman Healthcare Partners LLC 40,036$1,553,0000.44%
Virtus ETF Advisers LLC 11,435$443,0000.21%
KENNEDY CAPITAL MANAGEMENT LLC 131,414$5,096,0000.15%
View complete list of APREA THERAPEUTICS INC shareholders